BE857957A - Formes de dosage pharmaceutiques a effet prolonge - Google Patents

Formes de dosage pharmaceutiques a effet prolonge

Info

Publication number
BE857957A
BE857957A BE180306A BE180306A BE857957A BE 857957 A BE857957 A BE 857957A BE 180306 A BE180306 A BE 180306A BE 180306 A BE180306 A BE 180306A BE 857957 A BE857957 A BE 857957A
Authority
BE
Belgium
Prior art keywords
long
dosage forms
pharmaceutical dosage
term pharmaceutical
term
Prior art date
Application number
BE180306A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of BE857957A publication Critical patent/BE857957A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE180306A 1976-08-20 1977-08-19 Formes de dosage pharmaceutiques a effet prolonge BE857957A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71631476A 1976-08-20 1976-08-20

Publications (1)

Publication Number Publication Date
BE857957A true BE857957A (fr) 1978-02-20

Family

ID=24877552

Family Applications (1)

Application Number Title Priority Date Filing Date
BE180306A BE857957A (fr) 1976-08-20 1977-08-19 Formes de dosage pharmaceutiques a effet prolonge

Country Status (11)

Country Link
US (1) US4137300A (fr)
JP (1) JPS5326318A (fr)
BE (1) BE857957A (fr)
DE (1) DE2736794A1 (fr)
DK (1) DK371277A (fr)
ES (1) ES461742A1 (fr)
FR (1) FR2361915A1 (fr)
IL (1) IL52769A0 (fr)
NL (1) NL7709103A (fr)
SE (1) SE7709359L (fr)
ZA (1) ZA775043B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH647676A5 (fr) * 1978-12-22 1985-02-15 Donald E Panoz Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4765985A (en) * 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
JPH0764723B2 (ja) * 1986-10-15 1995-07-12 鐘紡株式会社 腸溶性製剤の製造法
US5192563A (en) * 1986-10-22 1993-03-09 Wm. Wrigley, Jr. Company Strongly mint-flavored chewing gums with reduced bitterness and harshness
US5112625A (en) * 1989-02-15 1992-05-12 Wm. Wrigley Jr. Company Aqueous zein coated sweeteners and other ingredients for chewing gum
US5021248A (en) * 1988-09-19 1991-06-04 Enzytech, Inc. Hydrophobic protein microparticles and preparation thereof
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DE4301782C1 (de) * 1993-01-23 1994-08-25 Lohmann Therapie Syst Lts Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
DE4342173A1 (de) * 1993-12-10 1995-06-14 Lohmann Therapie Syst Lts Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
WO1998026766A1 (fr) * 1996-12-18 1998-06-25 Fractales Biotech Capsule biodegradable a base d'une prolamine
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
WO1999017738A1 (fr) 1997-10-03 1999-04-15 Lavipharm Laboratories, Inc. Composition a base de prolamines et de lipides polaires d'origine vegetale, procede de fabrication et applications
JPH11189666A (ja) 1997-12-26 1999-07-13 Showa Sangyo Co Ltd 多糖類成形体に耐水性を付与する方法
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906979B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
AU2005313887B2 (en) * 2004-12-09 2011-10-27 Celgene Corporation Treatment using D-threo methylphenidate

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE184774C (fr) *
CA579204A (fr) * 1959-07-07 H. Clark Roy Methode de production de composition therapeutique a degagement soutenu
US874310A (en) * 1906-01-16 1907-12-17 Eugene Donard Pharmaceutical coating.
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
GB935672A (en) * 1960-07-19 1963-09-04 Sterling Drug Inc Sustained release tablet
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
NL113366C (fr) * 1961-02-24
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
GB1063872A (en) * 1962-08-11 1967-03-30 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical compositions
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
ZA722664B (en) * 1971-05-18 1973-01-31 Smith Kline French Lab Lyered bolus for animal husbandry providing for immediate and sustained release of medicament
GB1443923A (en) * 1972-05-02 1976-07-28 Shepard M Sustained release compositions

Also Published As

Publication number Publication date
ZA775043B (en) 1978-07-26
JPS5326318A (en) 1978-03-11
IL52769A0 (en) 1977-10-31
FR2361915A1 (fr) 1978-03-17
ES461742A1 (es) 1978-05-01
DK371277A (da) 1978-02-21
DE2736794A1 (de) 1978-02-23
US4137300A (en) 1979-01-30
NL7709103A (nl) 1978-02-22
SE7709359L (sv) 1978-02-21

Similar Documents

Publication Publication Date Title
BE857957A (fr) Formes de dosage pharmaceutiques a effet prolonge
SE7803527L (sv) Lekemedelsdosenhet
SE7706056L (sv) Implanterbar doseringsanordning
SE7706055L (sv) Implanterbar doseringsanordning
KE3171A (en) Pharmaceutical dosage forms
SE7804890L (sv) Anordning for utmatning av lekemedel
FR2347922A1 (fr) Bas therapeutique perfectionne
FR2304354A1 (fr) Nouvelles compositions pharmaceutiques a activite retardee
BE871584A (fr) Preparations pharmaceutiques
DK155717C (da) Doseringsapparat
BE856811A (fr) Compositions pharmaceutiques basiques renfermant un preservateur
SE7811318L (sv) Doseringsanordning
SE7809373L (sv) Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
NL7711446A (nl) Pharmaceutische desinfecterend preparaat.
SE7703341L (sv) Doseringsapparat
FI763506A (fi) Farmaceutisk naeringsfoerpackning
FI773812A (fi) Farmaceutiska foereningar
BE868288A (fr) Soupape de dosage
IT8019430A0 (it) Formulazione farmaceutica a cessione protratta.
BE838507A (fr) Comprimes pharmaceutiques
BE816376A (fr) Compositions pharmaceutiques a base de creatine-phosphate et decreatine-phosphokinase
FI773813A (fi) Farmaceutiska foereningar
NL7805158A (nl) Farmaceutisch preparaat.
DD128671A5 (de) Pharmazeutische mittel
NL7812344A (nl) Farmaceutisch preparaat.